Document is current

Any future updates will be listed below

BEST-CLI and BASIL-2 Trials: Why Ethnicity, Diabetes Burden, and Population Differences Matter in the CLTI Revascularization Debate

Crossref DOI link: https://doi.org/10.1007/s00270-026-04406-6

Published Online: 2026-03-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark